Browse
Submit Data
Databases
API
Help

Dataset Information

10 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ECG Images dataset of Cardiac and COVID-19 Patients.

ABSTRACT: The study contains the dataset of ECG images of Cardiac and COVID-19 patients. This rare dataset contains 1937 distinct patient records, data is collected using ECG Device 'EDAN SERIES-3' installed in Cardiac Care and Isolation Units of different health care institutes across Pakistan. The collected ECG images data were manually reviewed by medical professors using Telehealth ECG diagnostic system, under the supervision of senior medical professionals with experience in ECG interpretation. The manual reviewing process of ECG images took several months to review the five distinct categories (COVID-19, Abnormal Heartbeat, Myocardial Infarction (MI), Previous History of MI, and Normal Person). The collected data contains 12 leads-based ECG images dataset can be used by Data Scientist, IT Professional and Medical Research Institutes to design, compare, fine-tune classical techniques and Deep learning methods in studies focused on COVID-19, Arrhythmia, and other cardiovascular conditions. The dataset contains rare categories of patients that may be used for the development of automatic diagnosis tool for healthcare institutes.

SUBMITTER: Khan AH

PROVIDER: S-EPMC7820911 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

ECG waveform dataset for predicting defibrillation outcome in out-of-hospital cardiac arrested patients.

Project description:The provided database of 260 ECG signals was collected from patients with out-of-hospital cardiac arrest while treated by the emergency medical services. Each ECG signal contains a 9 second waveform showing ventricular fibrillation, followed by 1 min of post-shock waveform. Patients' ECGs are made available in multiple formats. All ECGs recorded during the prehospital treatment are provided in PFD files, after being anonymized, printed in paper, and scanned. For each ECG, the dataset also includes the whole digitized waveform (9 s pre- and 1 min post-shock each) and numerous features in temporal and frequency domain extracted from the 9 s episode immediately prior to the first defibrillation shock. Based on the shock outcome, each ECG file has been annotated by three expert cardiologists, - using majority decision -, as successful (56 cases), unsuccessful (195 cases), or indeterminable (9 cases). The code for preprocessing, for feature extraction, and for limiting the investigation to different temporal intervals before the shock is also provided. These data could be reused to design algorithms to predict shock outcome based on ventricular fibrillation analysis, with the goal to optimize the defibrillation strategy (immediate defibrillation versus cardiopulmonary resuscitation and/or drug administration) for enhancing resuscitation.

| S-EPMC7753135 | biostudies-literature

Proteomic blood profiling in mild, severe and critical COVID-19 patients

Project description: Not available

| S-BSST416 | biostudies-other

QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients.

Project description:BackgroundQTc prolongation is an adverse effect of COVID-19 therapies. The use of a handheld device in this scenario has not been addressed.ObjectivesTo evaluate the feasibility of QTc monitoring with a smart device in COVID-19 patients receiving QTc-interfering therapies.MethodsProspective study of consecutive COVID-19 patients treated with hydroxychloroquine ± azithromycin ± lopinavir-ritonavir. ECG monitoring was performed with 12-lead ECG or with KardiaMobile-6L. Both registries were also sequentially obtained in a cohort of healthy patients. We evaluated differences in QTc in COVID-19 patients between three different monitoring strategies: 12-lead ECG at baseline and follow-up (A), 12-lead ECG at baseline and follow-up with the smart device (B), and fully monitored with handheld 6-lead ECG (group C). Time needed to obtain an ECG registry was also documented.ResultsOne hundred and eighty-two COVID-19 patients were included (A: 119(65.4%); B: 50(27.5%); C: 13(7.1%). QTc peak during hospitalization did significantly increase in all groups. No differences were observed between the three monitoring strategies in QTc prolongation (p = 0.864). In the control group, all but one ECG registry with the smart device allowed QTc measurement and mean QTc did not differ between both techniques (p = 0.612), displaying a moderate reliability (ICC 0.56 [0.19-0.76]). Time of ECG registry was significantly longer for the 12-lead ECG than for handheld device in both cohorts (p < 0.001).ConclusionQTc monitoring with KardiaMobile-6L in COVID-19 patients was feasible. Time of ECG registration was significantly lower with the smart device, which may offer an important advantage for prevention of virus dissemination among healthcare providers.

| S-EPMC8195254 | biostudies-literature

Tissue proteomics dataset of COVID-19 patients

Project description:Quantitative proteomic analysis of different tissues from COVID-19 patients was performed to assess the biological changes.

2020-06-22 | PXD019970 |

Plasma proteomics dataset of COVID-19 patients

Project description:Quantitative proteomic analysis of plasma from different time courses of fatal, severe, and mild COVID-19 patients was performed to assess the biological changes during treatment.

2020-06-22 | PXD019106 |

Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.

Project description:ObjectivesThis study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions.BackgroundUnwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown.Methods100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to front (PF); and prone with precordial leads attached to back in a mirror image to front (PB).ResultsProne positioning was associated with QTc prolongation (PF 437 ± 32 ms vs. SF 432 ± 31 ms; p < 0.01; PB 436 ± 34 ms vs. SF 432 ± 31 ms; p = 0.02). In leads V1 to V3 on PB ECG, a qR morphology was present in 90% and changes in T-wave polarity in 84%. In patients with anterior ischemia, ST-segment changes in V1 to V3 on supine ECG were no longer visible on PB in 100% and replaced by an R-wave in V1. Bundle branch block (BBB) remained detectable in 100% on PB, with left BBB appearing as right BBB on PB in 71% and QRS narrowing with qR in V1 for right BBB. ST-segment/T-wave changes in limb leads and arrhythmia detection were largely unaffected in PB.ConclusionsAs expected, the PB ECG is unreliable for the detection of anterior myocardial injury but remains useful for ST-segment/T-wave abnormalities in limb leads, BBB detection, and rhythm monitoring. The prone ECG is a useful screening tool with diagnostic utility in COVID-19 patients who require prone ventilation.

| S-EPMC8245052 | biostudies-literature

Proximal Tubular Dysfunction as a Predictor of AKI in Hospitalized COVID-19 Patients

Project description: Not available

| S-BSST1269 | biostudies-other

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms

Project description: Not available

| S-BSST719 | biostudies-other

Proteomics dataset of COVID-19 and control patients

Project description:Proteomics dataset of COVID-19 and control patients

2021-10-14 | PXD029023 |

Effects of Dexamethasone in COVID-19 patients

Project description:Dexamethasone improves the survival of COVID-19 patients in need of supplemental oxygen therapy. Hospitalized COVID-19 patients eligible for dexamethasone therapy were recruited from the general care ward in several centers in Greece and the Netherlands and whole blood transcriptomic analysis was performed before and after starting dexamethasone treatment. Peripheral blood mononuclear cells (PBMCs) were isolated from healthy individuals and COVID-19 patients and stimulated with inactivated SARS-CoV-2 ex vivo in the presence or absence of dexamethasone and their transcriptome was assessed.

2023-07-26 | GSE227585 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data